Back to 
TWO SIGMA INVESTMENTS, LP
TWO SIGMA INVESTMENTS, LP
SABS2 quarters
Position history for TWO SIGMA INVESTMENTS, LP's holdings in SAB BIOTHERAPEUTICS INC
Yes. Two Sigma holds 214,632 shares of SABS (Sab Biotherapeutics), worth $837,065, as of its Q2 2026 13F filing. It increased the position by 33,447 shares (+18.5%) from Q1 2026. Two Sigma has held SABS since Q1 2026, across 2 quarterly 13F filings.
Current Value
$837,065
Current Shares
214,632
Total Value Change
+$143,126
Total Shares Change
+33,447
Quarter-by-Quarter History
Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.